This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Uncategorised Disease
  • /
  • Novel targeted therapies for resistant ALK-rearran...

Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond.

Read time: 1 mins
Published:25th Mar 2020
Author: Kanaan Z, Kloecker GH, Paintal A, Perez CA.
Ref.:Onco Targets Ther. 2015 Apr 20;8:885-92.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest